Shulamith Rizel

D538G Mutation in Estrogen Receptor-α: A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer

Keren Merenbakh-Lamin, Noa Ben-Baruch, Adva Yeheskel et al. · Cancer Research · 2013 · 395 citations

Breast Oncology, Estrogen Receptor-α, Genetics +20

Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31

Karen A. Gelmon, Frances Boyle, Bella Kaufman et al. · Journal of Clinical Oncology · 2015 · 183 citations · Full text

Doxorubicin-induced ovarian toxicity

Irit Ben‐Aharon, Hadas Bar‐Joseph, Galia Tzarfaty et al. · Reproductive Biology and Endocrinology · 2010 · 165 citations · Full text

Doxorubicin-induced apoptosis in germinal vesicle (GV) oocytes

Hadas Bar‐Joseph, Irit Ben‐Aharon, Shulamith Rizel et al. · Reproductive Toxicology · 2010 · 94 citations

Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry

Salomon M. Stemmer, Mariana Steiner, Shulamith Rizel et al. · npj Breast Cancer · 2017 · 85 citations · Full text